Phase 2 Trial of Stem Cell Therapy in Parkinson’s Patients Enrolling

A newly opened Phase 2 clinical trial is evaluating adult stem cells as a potentially disease-modifying treatment for Parkinson’s, building on an earlier study, thought to be the first of its kind, that found a single infusion of these cells safe and well tolerated by patients. This study will use mesenchymal stem cells, which are found [...]

Published April 22, 2021 at 07:55AM. Read full article at Stem Cells in the News Portal.